Security key
68235C107
Oncocyte Corporation - Common Shares, No Par Value (OCX)
CUSIP: 68235C107
Q2 2021 13F Holders as of 30 Jun 2021
- Security type / class
- Equity / Common Shares, No Par Value
- Total 13F shares
- 56,557,145
- Total 13F value
- $324,629,337
- Share change
- +1,707,999
- Put/Call ratio
- 48%
- SEC-reported price per share
- $5.74
- Number of holders
- 88
- Value change
- +$10,097,713
- Number of buys
- 39
- Number of sells
- 42
- Shares outstanding
- 28,495,649
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2021
Institutions
88
Top holders
10
OCX full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2021
Previous quarter: Q1 2021
Insight Molecular Diagnostics Inc. SEC filings
Insight Molecular Diagnostics Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 68235C107
Recent filing periods:
Ownership snapshot
Top reported holders of OCX - Oncocyte Corporation - Common Shares, No Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
BROADWOOD CAPITAL INC
Disclosed value leader
BROADWOOD CAPITAL INC
Comparable rows
15/15
Latest evidence
31 Mar 2021
13F
Lead comparable stake: 59%
Showing 1-6 of 15 holder rows.
Quick read
BROADWOOD CAPITAL INC leads the comparable SEC ownership view at 59%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens BROADWOOD CAPITAL INC's linked filing trail.
Comparable ownership
Top 5
BROADWOOD CAPITAL INC
59%
PURA VIDA INVESTMENTS, LLC
43%
BlackRock Finance, Inc.
17%
VANGUARD GROUP INC
13%
ORBIMED ADVISORS LLC
7.4%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| BROADWOOD CAPITAL INC |
13F
Company
|
59%
|
$87,070,000
16,776,484 shares
|
— | 31 Mar 2021 |
| PURA VIDA INVESTMENTS, LLC |
13F
Company
|
43%
|
$63,442,000
12,223,953 shares
|
— | 31 Mar 2021 |
| BlackRock Finance, Inc. |
13F
Company
|
17%
|
$25,784,000
4,968,214 shares
|
— | 31 Mar 2021 |
| VANGUARD GROUP INC |
13F
Company
|
13%
|
$19,495,000
3,756,257 shares
|
— | 31 Mar 2021 |
| ORBIMED ADVISORS LLC |
13F
Company
|
7.4%
|
$10,899,000
2,100,000 shares
|
— | 31 Mar 2021 |
| Schonfeld Strategic Advisors LLC |
13F
Company
|
5.7%
|
$8,423,000
1,622,824 shares
|
— | 31 Mar 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
88
Shares
56,557,145
Rows available
88
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
84
Q2 2021 holders
88
Holder diff
4
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 value | Q2 2021 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend